Trarbach, Ericka B. http://orcid.org/0000-0003-4570-2439
Trivellin, Giampaolo http://orcid.org/0000-0003-2384-4153
Grande, Isabella P. P. http://orcid.org/0000-0003-2986-4286
Duarte, Felipe H. G. http://orcid.org/0000-0002-3495-1301
Jorge, Alexander A. L. http://orcid.org/0000-0003-2567-7360
do Nascimento, Felipe Barjud Pereira http://orcid.org/0000-0003-4319-3386
Garmes, Heraldo M. http://orcid.org/0000-0001-6117-8548
Nery, Marcia http://orcid.org/0000-0003-2415-9668
Mendonca, Berenice B. http://orcid.org/0000-0003-1762-1084
Stratakis, Constantine A. http://orcid.org/0000-0002-4058-5520
Bronstein, Marcello D. http://orcid.org/0000-0002-0113-5201
Jallad, Raquel S. http://orcid.org/0000-0003-0477-1892
Funding for this research was provided by:
National Institute of Child Health and Human Development
Article History
Accepted: 26 October 2020
First Online: 6 November 2020
Compliance with ethical standards
:
: EBT, IPPG, FHGD, AALJ, FBPN, HMG, MN, BBM, MDB and RSJ have nothing to declare. CAS and GT hold a patent on the <i>GPR101</i> gene and its function and have received funding from Pfizer, Inc., on growth hormone and acromegaly research. CAS also holds patents on <i>PRKAR1A</i> and <i>PDE11A</i> genes and their function.
: This study was approved by the local Ethics Committee and an Informed Consent form was obtained from All Patients or their Legal Guardian.